StocksMedium•5 November 2026•
1 min read
Kailera Therapeutics Reports Q3 Loss of $0.74 Per Share, Beating Estimates
Key Facts
1Kailera Therapeutics reported a quarterly loss of $0.74 per share for the third quarter.
2The company's results beat analyst consensus estimates of $1.02 per share by 27.45 percent.
Kailera Therapeutics reported a quarterly loss of $0.74 per share for the third quarter of 2026. According to scanx.trade, the company's results beat analyst consensus estimates of a $1.02 loss per share by 27.45 percent.
KLRA closed at $12.8 on November 4, 2026, with the stock trading between a low of $12.15 and a high of $13.19 during that session. While the company remains loss-making, the significant variance from market projections indicates a stronger financial performance than modeled by analysts.